Excessive activation of effector CD4+ T cells and/or reductions in CD4+ T cell-mediated tolerance to gut antigens are thought to play a role in the development of the two most common forms of IBD, ulcerative colitis (UC) and Crohn’s disease (CD) [1, 2]. The gene discussed is CD4; the disease is Crohn disease.